Stocks
Intellia Therapeutics (NTLA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -29.5 | -3.60 | -3.77 | -1.45 | -1.56 | -3.33 | ||
| Changes by years, y/y, % | +55% | -88% | +5% | -61% | +7% | -39.4% | |||
Intellia Therapeutics. EV/EBITDA
Intellia Therapeutics. EV/EBITDA, changes, %
Intellia Therapeutics (NTLA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -0.66 | -1.23 | -3.27 | -1.48 | -3.08 | -3.33 | |
| Changes by years, y/y, % | -83% | -60% | +13% | -3% | +365% | |||
| Changes by quarters, q/q, % | -56% | +85% | +166% | -55% | +108% | |||
